)
Cue Biopharma (CUE) investor relations material
Cue Biopharma AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order by Interim President and CEO, with introductions of board members and meeting officials.
Agenda included election of directors, ratification of auditor, executive compensation approval, and a reverse stock split proposal.
Shareholder proposals
Four proposals presented: election of six directors, ratification of RSM US LLP as auditor for 2026, advisory approval of executive compensation, and approval of a reverse stock split within a 1-for-30 to 1-for-50 range.
Overview of voting outcomes
All six director nominees were elected.
Auditor ratification, executive compensation, and the reverse stock split amendment were all approved by shareholders.
- Advancing to Phase 1, the bifunctional therapy targets autoimmune diseases with strong preclinical data.CUE
R&D Day 202613 Apr 2026 - Director resignation leads to interim CEO appointment and board size reduction.CUE
Proxy filing27 Mar 2026 - Biotech seeks up to $300M in securities amid going concern risk and ongoing capital needs.CUE
Registration Filing17 Mar 2026 - Q4 2025 revenue soared on ImmunoScape deal, with CUE-401 advancing and liquidity improved.CUE
Q4 202516 Mar 2026 - Key votes include director elections, auditor ratification, and a reverse stock split to support Nasdaq compliance.CUE
Proxy Filing16 Mar 2026 - Proxy seeks approval for director elections, auditor, executive pay, and a reverse stock split.CUE
Proxy Filing6 Mar 2026 - Obesity phase III trials advance, with strong oral efficacy and new maintenance strategies underway.CUE
Cantor Global Healthcare Conference 20253 Feb 2026 - Selective immune modulation platform shows strong clinical efficacy and regulatory momentum.CUE
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Restructuring and clinical gains drive focus on autoimmune pipeline amid cash constraints.CUE
Q2 20241 Feb 2026
Next Cue Biopharma earnings date
Next Cue Biopharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)